| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0041 | 0.9 |